We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$218B
AUM Growth
+$17B
Cap. Flow
+$6.68B
Cap. Flow %
3.06%
Top 10 Hldgs %
22.81%
Holding
10,425
New
1,217
Increased
3,775
Reduced
3,854
Closed
1,335

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$400M
2
C icon
Citigroup
C
+$395M
3
CELG
Celgene Corp
CELG
+$360M
4
AMZN icon
Amazon
AMZN
+$347M
5
RTX icon
RTX Corp
RTX
+$344M

Sector Composition

Rank Sector Weight
1 Technology 5.61%
2 Financials 4.93%
3 Healthcare 4%
4 Consumer Discretionary 3.82%
5 Industrials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSAT icon
8401
Globalstar
GSAT
$10.7B
$81K ﹤0.01%
11,378
-6,125
-35% -$47.9K
TUSK icon
8402
Mammoth Energy Services
TUSK
$160M
$81K ﹤0.01%
+11,752
New +$149K
TGEN
8403
Tecogen Inc
TGEN
$109M
$81K ﹤0.01%
21,730
-10,522
-33% -$38.8K
CDMO
8404
CALL
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$81K ﹤0.01%
14,500
-2,700
-16% -$11.1K
CEN
8405
DELISTED
Center Coast Brookfield MLP & Energy Infrastructure Fund
CEN
$81K ﹤0.01%
+1,027
New +$84.6K
ALTO icon
8406
CALL
Alto Ingredients
ALTO
$324M
$80K ﹤0.01%
104,000
+5,400
+5% +$5.51K
ICAD
8407
PUT
DELISTED
iCAD Inc
ICAD
$80K ﹤0.01%
+12,500
New +$71.4K
RAIL icon
8408
FreightCar America
RAIL
$240M
$80K ﹤0.01%
+13,751
New +$88.8K
TMQ
8409
Trilogy Metals
TMQ
$646M
$80K ﹤0.01%
+27,020
New +$71.4K
DLNG icon
8410
Dynagas LNG Partners
DLNG
$140M
$79K ﹤0.01%
+54,497
New +$110K
SMC
8411
Summit Midstream
SMC
$482M
$79K ﹤0.01%
704
-724
-51% -$88.2K
MLNT
8412
PUT
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$79K ﹤0.01%
+11,900
New +$45.3K
CIA icon
8413
CALL
Citizens
CIA
$201M
$78K ﹤0.01%
+10,700
New +$73.3K
CTLP
8414
DELISTED
Cantaloupe
CTLP
$78K ﹤0.01%
10,450
-7,068
-40% -$43.8K
ISUN
8415
DELISTED
iSun, Inc. Common Stock
ISUN
$78K ﹤0.01%
+11,130
New +$111K
ARAY icon
8416
CALL
Accuray
ARAY
$33.2M
$77K ﹤0.01%
19,900
-3,200
-14% -$12.9K
CARM
8417
CALL
DELISTED
Carisma Therapeutics
CARM
$77K ﹤0.01%
+2,575
New +$77.1K
LXRX icon
8418
PUT
Lexicon Pharmaceuticals
LXRX
$1.03B
$77K ﹤0.01%
12,200
-274,900
-96% -$1.65M
ACH
8419
PUT
Accendra Health
ACH
$73.1M
$77K ﹤0.01%
24,200
+5,200
+27% +$17.7K
TWI icon
8420
Titan International
TWI
$445M
$77K ﹤0.01%
+15,676
New +$85.3K
RMTI icon
8421
CALL
Rockwell Medical
RMTI
$29.2M
$76K ﹤0.01%
230
-195
-46% -$99K
CNR
8422
PUT
DELISTED
Cornerstone Building Brands, Inc.
CNR
$76K ﹤0.01%
13,000
-9,700
-43% -$53.9K
GYRE icon
8423
CALL
Gyre Therapeutics
GYRE
$708M
$75K ﹤0.01%
1,360
-13
-0.9% -$812
HIX
8424
Western Asset High Income Fund II
HIX
$354M
$75K ﹤0.01%
10,621
-71,139
-87% -$474K
PBPB
8425
CALL
DELISTED
Potbelly
PBPB
$75K ﹤0.01%
14,800
-400
-3% -$2.72K

Similar funds

Citadel Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Citadel Advisors held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Citadel Advisors deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.

  • Citadel Advisors's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
  • Citadel Advisors added most to Netflix in Q2 2019, an estimated $400M increase.
  • Citadel Advisors's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
  • Citadel Advisors fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
  • Citadel Advisors's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
  • Citadel Advisors opened 1,217 new positions and closed 1,335 in Q2 2019.
  • Citadel Advisors's portfolio value rose 8.5% quarter-over-quarter to $218B.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.